Pharmaceutical Technology

JULY 5, 2022

Through the Impact brand, which comprises insulin, glibenclamide and oxaliplatin among others, the company will supply its 30 medicines in 40 lower-income countries in the world. The post Sanofi unveils global health brand for medicines supply appeared first on Pharmaceutical Technology.

Branding 147

Branding Medicine Insulin Antibody 147

STAT News

JANUARY 20, 2023

In an attempt to tackle the root causes of inflated insulin prices, the state of California filed a lawsuit last week accusing drug manufacturers and pharmacy benefit managers of artificially and illegally jacking up the price of insulin. The sausage-making of how insulin is priced is not for the faint of heart.

Insulin 105

Insulin Pharmacy Manufacturing Drugs 105

STAT News

OCTOBER 18, 2022

Amid ongoing controversy over the cost of insulin, a new analysis finds that approximately 1.3 Among all insulin users, the most common rationing tactic was to simply delay purchases, with 14.5% Among all insulin users, the most common rationing tactic was to simply delay purchases, with 14.5% million people, or 16.5%

Insulin 105

Insulin Medicine 105

Medical Xpress

NOVEMBER 15, 2022

In a new 'Ideas and Opinions,' authors from Johns Hopkins Bloomberg School of Public Health analyze California's newly announced effort to manufacture insulin for its residents. The commentary is published in Annals of Internal Medicine.

Insulin 98

Insulin Manufacturing Medicine Drugs 98

Medical Xpress

APRIL 11, 2023

An international study shows that it is likely that insulin can be stored at room temperature, and for considerably longer than drug companies have counted on to date. Access to this vital medicine can thereby be significantly improved for the world's poorest inhabitants.

Insulin 98

Insulin Scientist Medicine Drugs 98

pharmaphorum

JULY 5, 2022

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the company last year. Insulin in particular has been singled out by the WHO as being a difficult medicine to access for many people around the world.

Medicine 119

Medicine Insulin Branding Vaccine 119

Fierce Pharma

SEPTEMBER 19, 2023

Novo Nordisk, following a similar move by its diabetes rival Eli Lilly, is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medi | Novo Nordisk is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medicine.

Insulin 85

Insulin Medicine 85

Scienmag

MARCH 15, 2022

For millions of people with diabetes, insulin is essential medicine. But for some ocean-dwelling predators, insulin is a weapon. With a burst of venom, a fish-hunting cone snail can drop the blood sugar of its prey so precipitously that it quickly becomes paralyzed and defenseless.

Insulin 82

Insulin Scientist Medicine 82

Medical Xpress

FEBRUARY 15, 2023

Significant physiologic decrease in insulin resistance during mid-adolescence may stop and reverse arterial stiffness progression, a paper published in the American Journal of Physiology-Endocrinology and Metabolism concludes. and the University of Eastern Finland.

Insulin 96

Insulin Medicine Cardiology 96

Pharmaceutical Technology

FEBRUARY 24, 2023

(LAI-287 + semaglutide) overview A fixed dose combination of GLP-1 analogue semaglutide and LAI-287, long-acting basal insulin is under development for the treatment of type 2 diabetes. The drug candidate is administered as an subcutaneous formulation.The combination acts by targeting GLP-1R and insulin receptor.

Insulin 182

Insulin Hormones Drugs Clinical Trials 182

Drug Patent Watch

JANUARY 13, 2025

These highly similar versions of approved biologic medicines offer a beacon of hope for patients and healthcare systems alike, promising increased accessibility and affordability of crucial treatments. ”[1] The global biosimilars market is experiencing exponential growth, with projections indicating it will reach $69.4

Marketing 78

Marketing Insulin Generic Drugs Medicine 78

Scienmag

MARCH 20, 2021

Study finds Omnipod® 5 simplifies diabetes management in type 1 diabetes WASHINGTON–People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy.

Insulin 71

Insulin Engineer Medicine 71

Velocity Clinical Research

JULY 27, 2023

Julio Rosenstock, MD, has his work spotlighted as the feature article on the New England Journal of Medicine’s homepage. Serving as the lead investigator for Novo Nordisk’s ONWARDS 1 program, Dr. Rosenstock has made remarkable strides in exploring what could be the world’s first once-weekly basal insulin. “In

Insulin 52

Insulin Medicine Clinical Research Research 52

Pharmaceutical Technology

JANUARY 10, 2023

Hailed as a breakthrough, Tzield’s approval marks the first of its kind to be introduced since the discovery of insulin, which won the 1923 Nobel Prize in the category of Physiology or Medicine. These therapies work by reprogramming the immune system, preventing it from attacking and eradicating insulin-producing cells in the pancreas.

Insulin 246

Insulin FDA Approval Research Development 246

Pharmaceutical Technology

JUNE 29, 2022

The next wave of medicine is well on course to be cell and gene-based. In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

The Pharma Data

AUGUST 17, 2021

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52

Insulin FDA Approval Doctors Doctor 52

JAMA Internal Medicine

FEBRUARY 28, 2021

This cohort study compares the associations of long-acting insulin analogs and NPH insulin with the risk of severe hypoglycemia in older patients with type 2 diabetes.

Insulin 51

Insulin 51

XTalks

NOVEMBER 21, 2024

The findings of the study were published in The New England Journal of Medicine (NEJM) and recently presented at ObesityWeek 2024. These gut hormones are released in response to nutrient intake and play a crucial role in the incretin effect, which enhances insulin secretion. percent in the placebo group.

Sales 105

Sales Insulin Drugs Trials 105

pharmaphorum

MARCH 2, 2022

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8

Insulin 52

Insulin Marketing Doctors Doctor 52

The Pharma Data

APRIL 28, 2022

Novo Nordisk today announced headline results from the ONWARDS 2 trial, a phase 3a, 26-week efficacy and safety treat-to-target trial investigating once-weekly insulin icodec vs insulin degludec in 526 people with type 2 diabetes switching from daily insulin. events per patient year exposed to once-weekly insulin icodec and 0.27

Insulin 52

Insulin Trials Clinical Trials Clinical Trials 52

Scienmag

MAY 17, 2021

Findings point to possible treatment for smell loss Credit: Monell Chemical Senses Center, eNeuro PHILADELPHIA (May 17, 2021) – Researchers have known for some time that insulin plays a vital role in regeneration and growth in some types of neurons that relay environmental sensory information to our brains, such as sight.

Insulin 58

Insulin Research Medicine 58

BioTech 365

JANUARY 25, 2022

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Leader in Endocrinology Research Implements eGlycemic Management System … Continue reading (..)

Insulin 40

Insulin Medicine Research 40

The Pharma Data

SEPTEMBER 30, 2021

Lilly’s Insulin Lispro Injection, 100 units/mL — first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 — will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022 Insulin Lispro Injection can be ordered through all U.S.

Insulin 52

Insulin Pharmacy Branding Medicine 52

XTalks

FEBRUARY 24, 2021

The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Related: Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market.

Insulin 64

Insulin Production Drug Delivery Marketing 64

pharmaphorum

MAY 16, 2022

GLP-1 and GIP are hormones involved in blood sugar control and Mounjaro, a first-in-class medicine that activates both GLP-1 and GIP receptors, demonstrated improved blood sugar control. It was also compared to a placebo, a GLP-1 receptor agonist (semaglutide) and two long-acting insulin analogues. more than insulin degludec and 1.0%

FDA Approval 115

FDA Approval Insulin Drugs Hormones 115

The Pharma Data

JUNE 29, 2021

New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. Study also shows more people on Soliqua had improved blood sugar control without weight gain and without low blood sugar events (hypoglycemia) in first head-to-head comparison with premixed insulin.

Insulin 52

Insulin Medicine Compliance Marketing 52

Scienmag

JANUARY 26, 2021

publishers New Rochelle, NY, January 26, 2021–Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. Credit: Mary Ann Liebert, Inc.,

Insulin 55

Insulin Trials Gene Therapy Clinical Trials 55

XTalks

MARCH 15, 2024

The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab). It is estimated that more than 8 million Americans rely on insulin products to manage their diabetes.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

Medical Xpress

FEBRUARY 21, 2025

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

Insulin 82

Insulin Engineer Medicine Development 82

STAT News

MARCH 27, 2023

The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices for various medicines, the latest effort to scrutinize the controversial companies that occupy a crucial role in pharmaceutical pricing.

Pharmacy 111

Pharmacy Drugs Insulin Medicine 111

Delveinsight

AUGUST 18, 2021

In Type 2 diabetes, the body cells become resistant to insulin. The pancreas produces insulin that helps glucose get into cells to be used for energy. Due to Type 2 diabetes, either the body doesn’t make enough insulin or it doesn’t use insulin properly as a result the blood glucose or blood sugar gets too high.

Insulin 94

Insulin Marketing Development Drugs 94

BioTech 365

MAY 13, 2021

Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-024, a Novel Precision Medicine Product Candidate for Patients with Severe Insulin Resistant Diabetic Nephropathy (DN) Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-024, a Novel Precision Medicine Product Candidate for … Continue reading →

Insulin 40

Insulin Clinical Trials Clinical Trials Medicine 40

Pharmaceutical Technology

MARCH 29, 2023

The partnership pursues an innovative approach to discovering and developing new medicines, using many of the modality-agnostic precision medicine platforms of Evotec. Together with our BMS colleagues, we are confident that we will deliver new medicines that matter to patients with neurodegenerative diseases.”

Clinical Trials 130

Clinical Trials Clinical Trials Insulin Medicine 130

Pharmaceutical Technology

APRIL 10, 2023

Furthermore, Galvus can be used in combination with other medicinal products such as insulin when unable to offer adequate glycaemic control. It can be used as monotherapy or in initial combination with metformin when diabetes is not adequately controlled by diet and exercise alone.

Branding 130

Branding Drugs Insulin Production 130

STAT News

NOVEMBER 17, 2022

… UnitedHealth Group’s pharmacy benefits manager, OptumRx, will keep AbbVie’s Humira alongside up to three biosimilar medicines next year, Bloomberg News writes. After all, our work is more interesting when you pass along insights, tips, and secrets.

Insulin 96

Insulin Pharmacy Sales Medicine 96

The Pharma Data

MAY 6, 2021

The Tempo Pen is a modified version of Lilly ‘s existing prefilled, disposable insulin pen to which the Tempo Smart Button – pending CE (Conformité Européenne or European Conformity) marking – attaches. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin. About DexCom Inc.

Insulin 52

Insulin Medicine Production Hormones 52

The Pharma Data

FEBRUARY 25, 2021

and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Lilly will commercialize the pen platform, which will include the new app and Lilly’s connected insulin pen solutions.

Insulin 40

Insulin Medicine Hormones Development 40